BIOMAT Database Logo BIOMAT Database Logo

[Chemotherapy of MOPP and C-MOPP resistant cases of malignant lymphoma. (A preliminary report) (author's transl)]. 1980

K Kolarić, and R Tomek, and A Roth

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008770 Methylnitrosourea A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosomethylurea,N-Methyl-N-nitrosourea,NSC-23909,N Methyl N nitrosourea,NSC 23909,NSC23909
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Kolarić, and R Tomek, and A Roth
[A modified MOPP therapy on advanced malignant lymphoma (author's transl)].
May 1976, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Kolarić, and R Tomek, and A Roth
[Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
August 1976, Deutsche medizinische Wochenschrift (1946),
K Kolarić, and R Tomek, and A Roth
[Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)].
March 1981, Klinische Wochenschrift,
K Kolarić, and R Tomek, and A Roth
[Orbitopalpebral non-Hodgkin's malignant lymphoma: report on 4 cases (author's transl)].
January 1982, Journal francais d'ophtalmologie,
K Kolarić, and R Tomek, and A Roth
[Salvage chemotherapy in resistant malignant lymphomas (author's transl)].
January 1982, Bulletin du cancer,
K Kolarić, and R Tomek, and A Roth
[Ataxia-telangiectasia with immunodeficiency and malignant lymphoma. Report of two cases (author's transl)].
February 1981, Medicina clinica,
K Kolarić, and R Tomek, and A Roth
[Primary gastric non-Hodgkin malignant lymphoma. Report of 38 new cases (author's transl)].
November 1979, Journal de chirurgie,
K Kolarić, and R Tomek, and A Roth
[Two cases of primary intracerebral malignant lymphoma (author's transl)].
January 1975, No shinkei geka. Neurological surgery,
K Kolarić, and R Tomek, and A Roth
MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000).
January 2002, Journal of veterinary internal medicine,
K Kolarić, and R Tomek, and A Roth
[Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
February 1981, Wiener klinische Wochenschrift,
Copied contents to your clipboard!